切换至 "中华医学电子期刊资源库"

中华诊断学电子杂志 ›› 2016, Vol. 04 ›› Issue (03) : 184 -190. doi: 10.3877/cma.j.issn.2095-655X.2016.03.010

所属专题: 文献

消化系统疾病与心身医学观

功能性胃肠道疾病罗马诊断标准的历史变迁及标准Ⅳ
徐三荣1,()   
  1. 1. 200040 上海,复旦大学附属华山医院消化科
  • 收稿日期:2016-07-05 出版日期:2016-08-26
  • 通信作者: 徐三荣

The historical change of diagnostic criteria of Rome and Rome Ⅳ about functional gastrointestinal disorders

Sanrong Xu1,()   

  1. 1. Department of Gastroenterology, Huashan Hospital Affiliated to Fudan University, Shanghai 200040, China
  • Received:2016-07-05 Published:2016-08-26
  • Corresponding author: Sanrong Xu
  • About author:
    Corresponding author: Xu Sanrong, Email:
引用本文:

徐三荣. 功能性胃肠道疾病罗马诊断标准的历史变迁及标准Ⅳ[J/OL]. 中华诊断学电子杂志, 2016, 04(03): 184-190.

Sanrong Xu. The historical change of diagnostic criteria of Rome and Rome Ⅳ about functional gastrointestinal disorders[J/OL]. Chinese Journal of Diagnostics(Electronic Edition), 2016, 04(03): 184-190.

功能性胃肠道疾病(FGIDs)是最常见的消化科疾病,依据形态学和生理学异常来识别,这两种异常经常合并存在,包括动力紊乱、迷走兴奋性增高、黏膜和免疫功能改变、肠道菌群改变、中枢神经系统信息处理改变。肠-脑互动紊乱的研究是基于使用特殊的诊断标准,因此要进行FGIDs领域中新认识的传播。罗马Ⅳ标准在罗马Ⅲ基础上:(1)更新了基础和临床文献;(2)提供了胃肠道微生态、脑-肠互动、药物基因学组、生物-心理-社会、性别和对FGIDs跨学科认识的新信息;(3)尽可能减少不准确或偶尔会遭到诟病的名称;(4)采用最新的诊断标准;(5)使患者病症体验、生理学亚组或生物标记的资料具体化,以便采用更有针对性的治疗。笔者对FGIDs领域作了历史的回顾,从动力和结构紊乱对FGIDs作了区分,讨论了与罗马Ⅲ的不同,回顾了罗马委员会的工作过程,为FGIDs提供了一个生物-心理-社会的、病理生理学的定义,为患者的治疗提供一个手段。

Functional gastrointestinal disorders (FGIDs), the most common diseases in gastroenterology, are recognized by morphologic and physiological abnormalities which often occur in combination including motility disturbance, increased vagal excitability, altered mucosal and immune function, altered gut microbiota, and altered central nervous system processing.Research on these gut-brain interaction disorders is based on using specific diagnostic criteria.The Rome Foundation has played a pivotal role in creating diagnostic criteria, thus new knowledge in the field of FGIDs should be disseminated.Rome Ⅳ is a compendium of the accumulated knowledge since Rome Ⅲ was published 10 years ago.It improves upon Rome Ⅲ by: (1)updating the basic and clinical literatures; (2)offering new information on gut microenvironment, gut-brain interactions, pharmacogenomics, biopsychosocial, gender and cross-disciplinary understandings of FGIDs; (3)reducing the use of imprecise and occasionally stigmatizing terms when possible; (4)using updated diagnostic criteria; (5)incorporating information on illness experience, and physiological subgroups or biomarkers of patient that may lead to more targeted treatment.This introductory article offers a historical overview of the FGIDs field, differentiates FGIDs from motility and structural disorders, discusses the changes from Rome Ⅲ, reviews the Rome committee, provides a biopsychosocial and pathophysiological conceptualization of FGIDs, and offers an approach to patient care.

表1 功能性胃肠道疾病类别
A食管疾病 ?
A1功能性胸痛 A4癔症球
? A2功能性烧心 ? A5功能性吞咽困难
? A3反流性高敏感 ? ?
B胃十二指肠疾病 ?
? B1功能性消化不良 ? B3恶心和呕吐疾病
? B1a餐后不适综合征 ? B3a慢性恶心呕吐综合征
? B1b上腹痛综合征 ? B3b周期性呕吐综合征
? B2嗳气疾病 ? B3c大麻样剧吐综合征
? B2a胃上部过度嗳气 ? B4反刍综合征
? B2b胃过度嗳气C肠道疾病 ? ?
? C1肠易激综合征 ? C2功能性便秘
? IBS-C ? C3功能性腹泻
? IBS-D ? C4功能性胀气/紧缩
? IBS-M ? C5非特异性功能性肠病
? IBS-U ? C6鸦片类药物诱导的便秘
D中枢介导的胃肠道疼痛疾病 ?
? D1中枢介导性腹痛综合征 ? ?
? D2吸毒成瘾性肠综合征/鸦片类药物引起的胃肠道痛觉过敏 ? ?
E胆囊和Oddi括约肌疾病 ?
? E1胆道痛 ? ?
? E1a功能性胆囊疾病 ? ?
? E1b功能性胆道性Oddi疾病 ? ?
? E2功能性胰腺性Oddi疾病 ? ?
F直肠肛门疾病 ?
? F1大便失禁 ? F3功能性排便障碍
? F2功能性直肠肛门痛 ? F3a排便动力不足
? F2a肛提肌综合征 ? F3b排便协同失调
? F2b非特异性直肠肛门痛 ? ?
? F2c痉挛性肛门痛 ? ?
G儿童FGIDs:新生儿/婴儿 ?
? G1婴儿反流 ? G5功能性腹泻
? G2反刍综合征 ? G6婴儿排便困难
? G3周期性呕吐综合征 ? G7功能性便秘
? G4婴儿肠绞痛 ? ?
H儿童FGIDs:儿童/青少年 ?
? H1功能性恶心呕吐疾病 ? H2b肠易激综合征
? H1a周期性呕吐综合征 ? H2c腹型偏头痛
? H1b功能性恶心和功能性呕吐 ? H2d功能性腹痛-NOS
? ? H1b1功能性恶心 ?
? ? H1b2功能性呕吐 H3功能性排便障碍
? H2功能性腹痛疾病 H3a功能性便秘
? H2a功能性消化不良 H3b容纳能力不良性大便失禁
? ? H2a1餐后不适综合征 ?
? ? H2a2上腹疼痛综合征 ?
[1]
Drossman DA.Presidential address: gastrointestinal illness and biopsychosocial model[J]. Psychosom Med, 1998, 60(3): 258-267.
[2]
Pasricha PJ.Neurogastroenterology:a great career choice for aspiring gastroenterologists thinking about the future[J]. Gastroenterology, 2011, 140(4): 1126-1128.
[3]
Engel GL.Psychologic stress, vasodepressor (vasovagal) syncope, and sudden death[J]. Ann Intern Med, 1978, 89(3): 403-412.
[4]
Lipowski ZJ. Psychosomatic medicine: past and presentpart 1, historical background[J]. Can J Psychiatry, 1986, 31(1): 2-7.
[5]
Drossman DA.Functional GI disorders:what’s in a name? [J]. Gastroenterology, 2005, 128(7): 1771-1772.
[6]
Alvarez WC.Hysterical type of nongaseous abdominal bloating[J]. Arch Intern Med(Chic), 1949, 84(2): 217-245.
[7]
Accarino A,Perez F,Azpiroz F, et al.Abdominal distention results from caudo-ventral redistribution of contents[J]. Gastroenterology, 2009, 136(5): 1544-1551.
[8]
Drossman DA.Irritable bowel syndrome:a multifactorial disorder[J]. Hosp Pract (Off Ed), 1988, 23(9): 119-124, 126, 131-133.
[9]
Christensen J. Defining the irritable bowel syndrome[J]. Perspect Biol Med, 1994, 38(1): 21-35.
[10]
Engel GL.The clinical application of the biopsychosocial model[J]. Am J Psychiatry, 1980, 137(5): 535-544.
[11]
Kellow JE,Delvaux M,Azpiroz F, et al.Principles of applied neuro gastroenterology:physiology/motilitysensation[J]. Gut, 1999, 45(Suppl 2): Ⅱ17-Ⅱ24.
[12]
Wood JD,Alpers DH,Andrews PL.Fundamentals of neurogastroen terology[J]. Gut, 1999, 45(Suppl 2): Ⅱ6-Ⅱ16.
[13]
Pasricha PJ,Colvin R,Yates K, et al.Characteristics of patients with chronic unexplained nausea and vomiting and normal gastric emptying[J]. Clin Gastroenterol Hepatol, 2011, 9(7): 567-576.
[14]
Torsoli A,Corazziari E. The WTR’s, the delphic oracle and the Roman conclaves[J]. Gastroenterol Int, 1991(4): 44-45.
[15]
Milholland AV,Wheeler SG,Heieck JJ.Medical assessment by a delphi group opinion technic[J]. N Engl J Med, 1973, 288(24): 1272-1275.
[16]
Thompson WG,Dotevall G,Drossman DA, et al.Irritable bowel syndrome:a guideline for the diagnosis[J]. Gastroenterol Int, 1989(2): 92-95.
[17]
Klein KB.Controlled treatment trials in the irritable bowel syndrome:a critique[J]. Gastroenterology, 1988, 95(1): 232-241.
[18]
Drossman DA,Li Z,Andruzzi E, et al. U. S. householder survey of functional gastrointestinal disorders.Prevalence, sociodemography and health impact[J]. Dig Dis Sci, 1993, 38(9): 1569-1580.
[19]
Cotton PB,Durkalski V,Romagnuolo J, et al.Effect of endoscopic sphincterotomy for suspected sphincter of Oddi dysfunction on pain-related disability following cholecystectomy:the EPISOD randomized clinical trial[J]. JAMA, 2014, 311(20): 2101-2109.
[20]
Wong RK,Palsson OS,Turner MJ, et al.Inability of the Rome Ⅲ criteria to distinguish functional constipation from constipation-subtype irritable bowel syndrome[J]. Am J Gastroenterol, 2010, 105(10): 2228-2234.
[21]
Shekhar C,Monaghan PJ,Morris J, et al.Rome Ⅲ functional constipation and irritable bowel syndrome with constipation are similar disorders within a spectrum of sensitization, regulated by serotonin[J]. Gastroenterology, 2013, 145(4): 749-757.
[22]
Engsbro AL,Simren M,Bytzer P. Short-term stability of subtypes in the irritable bowel syndrome:prospective evaluation using the Rome Ⅲ classification[J]. Aliment Pharmacol Ther, 2012, 35(3): 350-359.
[23]
Spiegel BM,Farid M,Esrailian E, et al.Is irritable bowel syndrome a diagnosis of exclusion?a survey of primary care providers, gastroenterologists, and IBS experts[J]. Am J Gastroenterol, 2010, 105(4): 848-858.
[24]
Shah SS,Bhatia SJ,Mistry FP.Epidemiology of dyspepsia in the general population in Mumbai[J]. Indian J Gastroenterol, 2001, 20(3): 103-106.
[25]
Emad Qayed MD,Shanthi Srinivasan MD,Nikrad Shahnavaz MD.Sleisenger and Fordtrans’s gastrointestinal and liver disease[M].10th ed.Philadelphia: Saunders Elsevier,2016: 349-362.
[26]
Mayer EA,Savidge T,Shulman RJ.Brain-gut microbiome interac tions and functional bowel disorders[J]. Gastroenterology, 2014, 146(6): 1500-1512.
[27]
Cremon C,Stanghellini V,Pallotti F, et al.Salmonella gastroenteritis during childhood is a risk factor for irritable bowel syndrome in adulthood[J]. Gastroenterology, 2014, 147(1): 69-77.
[28]
Camilleri M,Carlson P,McKinzie S, et al.Genetic susceptibility to inflammation and colonic transit in lower functional gastrointestinal disorders:preliminary analysis[J]. Neurogastroenterol Motil, 2011, 23(10): 935-e398.
[29]
Tran L,Chaloner A,Sawalha AH, et al.Importance of epigenetic mechanismsin visceral pain induced by chronic water avoidance stress[J]. Psychoneuroendocrinology, 2013, 38(6): 898-906.
[30]
Levy RL,Whitehead WE,Walker LS, et al. Increased somatic complaints and health-care utilization in children:effects of parent IBS status and parent response to gastrointestinal symptoms[J]. Am J Gastroenterol, 2004, 99(12): 2442-2451.
[31]
Camilleri M. Peripheral mechanisms in irritable bowel syndrome[J]. N Engl J Med, 2012, 367(17): 1626-1635.
[32]
Piche T. Tight junctions and IBS-the link between epithelial perme ability, low-grade inflammation, and symptom generation?[J]. Neurogastroenterol Motil, 2014, 26(3): 296-302.
[33]
Matricon J,Meleine M,Gelot A, et al.Review article:associations between immune activation, intestinal permeability and the irritable bowel syndrome[J]. Aliment Pharmacol Ther, 2012, 36(11-12): 1009-1031.
[34]
Pigrau M,Rodin¨o-Janeiro BK,Casado-Bedmar M, et al.The joint power of sex and stress to modulate brain-gut-microbiota axis and intestinal barrier homeostasis:implications for irritable bowel syndrome[J]. Neurogastroenterol Motil, 2016, 28(4): 463-486.
[35]
Rajilić-Stojanović M,Jonkers DM,Salonen A, et al.Intestinal microbiota and diet in IBS:causes, consequences, or epiphenomena? [J]. Am J Gastroenterol, 2015, 110(2): 278-287.
[36]
Gaman A,Kuo B. Neuromodulatory processes of the brain-gut axis[J]. Neuromodulation, 2008, 11(4): 249-259.
[37]
Jones MP,Dilley JB,Drossman D, et al.Brain-gut connections in functional GI disorders:anatomic and physiologic relationships[J]. Neurogastroenterol Motil, 2006, 18(2): 91-103.
[38]
Mayer EA,Labus JS,Tillisch K, et al.Towards a systems view of IBS[J]. Nat Rev Gastroenterol Hepatol, 2015, 12(10): 592-605.
[1] 王亚红, 蔡胜, 葛志通, 杨筱, 李建初. 颅骨骨膜窦的超声表现一例[J/OL]. 中华医学超声杂志(电子版), 2024, 21(11): 1089-1091.
[2] 唐金侨, 叶宇佳, 王港, 赵彬, 马艳宁. 医学影像学检查方法在颞下颌关节紊乱病中临床应用研究进展[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(06): 406-411.
[3] 赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
[4] 屈翔宇, 张懿刚, 李浩令, 邱天, 谈燚. USP24及其共表达肿瘤代谢基因在肝细胞癌中的诊断和预后预测作用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 659-662.
[5] 熊鹰, 林敬莱, 白奇, 郭剑明, 王烁. 肾癌自动化病理诊断:AI离临床还有多远?[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 535-540.
[6] 王秋生. 胆道良性疾病诊疗策略[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 779-782.
[7] 袁雨涵, 杨盛力. 体液和组织蛋白质组学分析在肝癌早期分子诊断中的研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 883-888.
[8] 中华医学会器官移植学分会. 肝移植术后缺血性胆道病变诊断与治疗中国实践指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 739-748.
[9] 郑大雯, 王健东. 胆囊癌辅助诊断研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 769-773.
[10] 李浩, 陈棋帅, 费发珠, 张宁伟, 李元东, 王硕晨, 任宾. 慢性肝病肝纤维化无创诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 863-867.
[11] 谭瑞义. 小细胞骨肉瘤诊断及治疗研究现状与进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 781-784.
[12] 王子阳, 王宏宾, 刘晓旌. 血清标志物对甲胎蛋白阴性肝细胞癌诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 677-681.
[13] 陈慧, 邹祖鹏, 周田田, 张艺丹, 张海萍. 皮肤镜对头皮红斑性皮肤病辅助鉴别诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 692-698.
[14] 胡云鹤, 周玉焯, 付瑞瑛, 于凡, 李爱东. CHS-DRG付费制度下GB1分组住院费用影响因素分析与管理策略探讨[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 568-574.
[15] 朱旦华, 卢放根. 以腹水为主要特征的Castleman病16例[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 462-473.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?